Vanguard Group Inc Cryo Cell International Inc Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Cryo Cell International Inc stock. As of the latest transaction made, Vanguard Group Inc holds 129,814 shares of CCEL stock, worth $636,088. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129,814
Previous 118,235
9.79%
Holding current value
$636,088
Previous $753,000
10.62%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CCEL
# of Institutions
23Shares Held
1.01MCall Options Held
0Put Options Held
0-
Hamilton Lane Advisors LLC410KShares$2.01 Million1.73% of portfolio
-
Sfi Advisors, LLC Montclair, NJ165KShares$809,9700.62% of portfolio
-
Massmutual Trust CO Fsb111KShares$544,0710.02% of portfolio
-
Geode Capital Management, LLC Boston, MA45.8KShares$224,5710.0% of portfolio
-
Northern Trust Corp Chicago, IL36.7KShares$179,9080.0% of portfolio
About CRYO CELL INTERNATIONAL INC
- Ticker CCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 8,519,250
- Market Cap $41.7M
- Description
- Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...